Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nkgen Biotech Inc (NKGN)

Nkgen Biotech Inc (NKGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nkgen Biotech Inc 3001 DAIMLER STREET SANTA ANA CA 92705 USA

www.nkgenbiotech.com Employees: 26 P: 949-396-6830

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

NKGen Biotech Inc. is a clinical-stage biotechnology company. It focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies. NKGen Biotech Inc., formerly known as Graf Acquisition Corp. IV, is based in THE WOODLANDS, Texas.

Key Statistics

Overview:

Market Capitalization, $K 6,219
Enterprise Value, $K 38,629
Shares Outstanding, K 124,377
Annual Sales, $ 0 K
Annual Net Income, $ -44,290 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -29,410 K
EBIT, $ -26,970 K
EBITDA, $ -25,650 K
60-Month Beta 0.98
% of Insider Shareholders 10.36%
% of Institutional Shareholders 76.17%
Float, K 111,492
% Float 89.64%
Short Interest 748
Short Float 0.60%
Short Volume Ratio 0.00

Growth:

1-Year Return -92.19%
3-Year Return -99.50%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.95 on 10/07/25
Next Earnings Date 03/03/26
Earnings Per Share ttm -1.72
EPS Growth vs. Prev Qtr -733.33%
EPS Growth vs. Prev Year 43.45%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

NKGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity -0.47
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.56
Interest Coverage -15.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar